Table 1 Distribution of patients with cystic fibrosis and healthy subjects according to clinical laboratory markers

Sex (male)

32 (51.61)

30 (48.39)

0.860

Sex (female)

32 (48.50)

34 (51.50)

Age (years)

12.34 (11.48–13.21) ± 3.47

13.51 (12.34–14.68) ± 4.64

0.490

12.00 (6.00–23.00)

11.00 (9.00–25.00)

Weight (kg)

34.80 (31.47–38.12) ± 13.30

46.39 (42.75–50.02) ± 14.44

≤0.001

33.75 (12.70–74.20)

44 (25.80–87.90)

Height (m)

1.42 (1.37–1.46) ± 0.19

1.52 (1.49–1.56) ± 0.132

0.003

1.45 (1.00–1.74)

1.58 (1.20–1.87)

BMI

16.72 (15.93–17.50) ± 3.15

19.56 (18.72–20.40) ± 3.33

≤0.001

15.87 (11.30–28.63)

19.01 (13.46–27.13)

Shwachman–Kulczycki score

77.93 (76.20–79.67) ± 6.94

–

–

80.00 (60.00–90.00)

–

FVC%

78.61 (73.44–83.78) ± 20.68

95.78 (92.89–98.67) ± 11.56

≤0.001

80.50 (32.00–121.00)

93.00 (69.00–130.00)

FEV₁%

68.98 (63.38–74.59) ± 22.45

91.94 (87.70–96.17) ± 16.96

≤0.001

65.50 (19.00–117.00)

90.00 (41.00–125.00)

FEV₁/FVC

85.66 (82.77–88.54) ± 11.56 87.50 (52.00–107.00)

98.23 (95.99–100.47) ± 8.95 100.00 (74.00–125.00)

≤0.001

Borg rating (initial)

<0.001

0

48 (75.0%)

64 (100.0%)

1

12 (19.0%)

0 (0.0%)

2

3 (5.0%)

0 (0.0%)

3

1 (1.0%)

0 (0.0%)

Borg rating (end)

0

33 (52.0%)

56 (88.0%)

1

6 (9.0%)

1 (1.0%)

2

14 (22.0%)

4 (6.3%)

3

6 (9.0%)

0 (0.0%)

4

2 (3.0%)

0 (0.0%)

≤0.005

5

1 (1.0%)

0 (0.0%)

6

1 (1.0%)

2 (3.0%)

7

0 (0.0%)

1 (1.0%)

10

1 (1.0%)

0 (0.0%)